Skip to main content
Log in

Transcatheter arterial chemoembolization for hepatocellular carcinoma

  • First International Symposium on Treatment of Liver Cancer Kobe, Japan, 15–16 November 1987 Session 2: Chemotherapy, Immunotherapy and Radiotherapy
  • Chemoembolization, Hepatocellular Carcinoma
  • Published:
Cancer Chemotherapy and Pharmacology Aims and scope Submit manuscript

Summary

Hepatocellular carcinoma (HCC) was treated with transcatheter arterial chemoembolization (TACE) in a sample of 129 patients. The cumulative survival rate was 49% at 1 year and 22% at 2 years. The median survival time was 11.9 months. The survival rates at 1 year of 84 patients in Child's group A and 27 in Child's group B were 56% and 40%; out of 52 HCC patients with portal vein patent and 77 with portal vein invasion 75% and 40% survived, and the 1-year survival rates for 33 HCC patients with capsule intact, 14 with caspule broken and 82 with no capsule were 85%, 65% and 40% respectively. From the above results there were statistically significant differences in survival time in those with good clinical performance status by Child's classification, those showing patency of the portal vein and those where the capsule was present. Therefore, we would like to recommend, TACE of HCC in well-selected patients presenting with good clinical status, patency of the portal vein and without broken capsule, in order to achieve better clinical results.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Chen CM, Liu TJ, Luiway, Peng FK, Lai KH, Lee SD, Yang CF, Chiang JH (1984) Chemotherapy of hepatic tumor: intraarterial infusion chemotherapy for treating hepatocellular carcinoma with FAM regimen. Excerpta Medica, Tokyo, p 34

    Google Scholar 

  2. Child CG, Turcatte JG (1964) Surgery and portal hypertension. In: Child CG (ed) The liver and portal hypertension. W. B. Saunders Co, Philadelphia, p 50

    Google Scholar 

  3. Department of Health, Executive Yuan, R.O.C. (1983) Cancer Registry Annual Report in Taiwan area. 1981

  4. Falkson G, Moertel GC, Lavin P, Pretorius FJ, Carbone PP (1978) Chemotherapy studies in primary liver cancer. A prospective randomized clinical trial. Cancer 42: 2149

    Google Scholar 

  5. Falkson G, Macintyre MJ, Moertel GC, Johnson AL, Scherman CR (1984) Primary liver cancer. An eastern cooperative oncology group trial. Cancer 54: 970

    Google Scholar 

  6. Hsu HC, Lin WSJ, Tsai MJ (1983) Hepatitis-B surface antigen and hepatocellular carcinoma in Taiwan. With Special reference to types and localization of HBsAg in the tumor cells. Cancer 52: 1825

    Google Scholar 

  7. Liaw YF, Tai DI, Chu CM, Lin DY, Sheen IS, Chen TJ, Pao CC (1986) Early detection of hepatocellular carcinoma in patients with chronic type B hepatitis. A prospective study. Gastroenterology 90: 263

    Google Scholar 

  8. Lin DY, Liaw YF, Lee TY, Lai CM (1988) Hepatic arterial embolization in patients with unresectable hepatocellular carcinoma. A randomized controlled trial. Gastroenterology (in press)

  9. Liver Cancer Study Group of Japan (1979) Survey and follow up study of primary liver cancer in Japan. Report 4. Acta Hepatol Jpn (Tokyo) 20: 433

    Google Scholar 

  10. Nagasue M, Yukaya H, Hamada T, Hirose S, Kanashima R, Ionkuchi K (1984) The natural history of hepatocellular carcinoma. A study of 100 untreated cases. Cancer 54: 1461

    Google Scholar 

  11. Nakamura H, Tanaka T, Hori S, Yoshioka H, Kuroda C, Okamura J, Sakurai M (1983) Transcatheter embolization of hepatocellular carcinoma. Assessment of efficacy in cases of resection following embolization. Radiology 147: 401

    Google Scholar 

  12. Olweny CM (1975) Treatment of hepatocellular carcinoma with adriamycin. Preliminary communication. Cancer 36: 1250

    Google Scholar 

  13. Sato Y, Fujiwara K, Ogata I, Ohta Y, Hayashi S, Oka Y, Furui S, Oka H (1985) Transcatheter arterial embolization for hepatocellular carcinoma. Benefits and limitations for unresectable cases with liver cirrhosis evaluated by comparison with other conservative treatments. Cancer 55: 2822

    Google Scholar 

  14. Sciarrino E, Simonetti GR, Moli LS, Pagliaro L (1985) Adriamycin treatment for hepatocellular carcinoma. Experience with 109 patients. Cancer 56: 2751

    Google Scholar 

  15. Sheu JC, Sung JL, Chen DS, Yu JY, Wang TH, Su CT, Tsang YM (1984) Ultrasonography of small hepatic tumors using high-resolution linear-array real-time instruments. Radiology 150: 797

    Google Scholar 

  16. Sheu JC, Sung JL, Chen DS, Lai MY, Wang TH, Yu JY, Yang PM, Chuang CN, Yang PC, Lee CS, Hsu HC, How SW (1985) Early detection of hepatocellular carcinoma by real-time ultrasonography. A prospective study. Cancer 56: 660

    Google Scholar 

  17. Yamada S, Sato M, Kawabata M, Nakatsuka N, Nakamua K, Takashima S (1983) Hepatic artery embolization in 120 patients with unresectable hepatoma. Radiology 148: 397

    Google Scholar 

  18. Yang PM, Chuang JN, Chen DS, Lai MY, Shen JC, Wang CY, Wang TH, Yu JY, Sung JL (1984) Chemotherapy or hepatocellular carcinoma with adriamycin alone and with FAN regimen. Excepta Medica, Tokyo, p 41

    Google Scholar 

  19. Vincent PC, Wallace S (1981) Hepatic artery embolization in the treatment of hepatic neoplasms. Radiology 140: 51

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yang, CF., Ho, YZ., Chang, JM. et al. Transcatheter arterial chemoembolization for hepatocellular carcinoma. Cancer Chemother. Pharmacol. 23 (Suppl 1), S26–S28 (1989). https://doi.org/10.1007/BF00647234

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00647234

Keywords

Navigation